Equillium, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Equillium, Inc. on August 29, 2025, regarding a corporate event related to its listing status on The Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on regulatory compliance status.
Material Changes
On August 29, 2025, the Company received notification from Nasdaq that it has regained compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)). This resolves a non-compliance notice originally issued on December 13, 2024, and a subsequent 180-day extension granted on June 12, 2025. Compliance was achieved when the common stock maintained a closing bid price of $1.00 per share or more for 10 consecutive business days, ending on August 28, 2025.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operations, or discussion of new risks. The primary contingency addressed was the risk of delisting due to failure to meet the $1.00 minimum bid price, which has now been resolved.
Key Facts for Investor Verification
- Equillium, Inc. has officially regained compliance with Nasdaq's minimum bid price rule.
- The stock price sustained the required $1.00 threshold for 10 consecutive business days through August 28, 2025.
- The immediate risk of delisting from The Nasdaq Capital Market due to low bid price has been removed.
- No financial performance data is included in this specific filing.